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Abstract
Background: RdCVF and RdCVF2, encoded by the nucleoredoxin-like genes NXNL1 and NXNL2, are trophic factors with
therapeutic potential that areinvolved incone photoreceptorsurvival. Studyinghowtheir expressionisregulatedin the retina
has implications for understanding both their activity and the mechanisms determining cell-type specificity within the retina.
Methodology/Principal Findings: In order to define and characterize their promoters, a series of luciferase/GFP reporter
constructs that contain various fragments of the 59-upstream region of each gene, both murine and human, were tested in
photoreceptor-like and non-photoreceptor cell lines and also in a biologically more relevant mouse retinal explant system.
For NXNL1,5 9-deletion analysis identified the human 2205/+57 bp and murine 2351/+51 bp regions as having promoter
activity. Moreover, in the retinal explants these constructs drove expression specifically to photoreceptor cells. For NXNL2,
the human 2393/+27 bp and murine 2195/+70 bp regions were found to be sufficient for promoter activity. However,
despite the fact that endogenous NXNL2 expression is photoreceptor-specific within the retina, neither of these DNA
sequences nor larger upstream regions demonstrated photoreceptor-specific expression. Further analysis showed that a
79 bp NXNL2 positive regulatory sequence (2393 to 315 bp) combined with a 134 bp inactive minimal NXNL1 promoter
fragment (277 to +57 bp) was able to drive photoreceptor-specific expression, suggesting that the minimal NXNL1
fragment contains latent elements that encode cell-type specificity. Finally, based on bioinformatic analysis that suggested
the importance of a CRX binding site within the minimal NXNL1 fragment, we found by mutation analysis that, depending
on the context, the CRX site can play a dual role.
Conclusions/Significance: The regulation of the Nucleoredoxin-like genes involves a CRX responsive element that can act
as both as a positive regulator of promoter activity and as a modulator of cell-type specificity.
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Introduction
Retinitis pigmentosa (RP) is a genetically and clinically
heterogeneous group of inherited retinal degenerative diseases
that causes severe visual impairment in as many as 2 million
patients worldwide [1,2]. Most identified forms of RP are caused
by mutations in genes whose expression is enriched in or restricted
to rod photoreceptor cells [3,4]. The loss of rods in RP is generally
followed by a secondary degeneration of cone photoreceptors
[5,6]. It is this secondary loss of cones that is most significant
clinically because cones are required for high acuity, color, and
most daylight vision. In the vast majority of cases, RP and related
forms of retinal degeneration are untreatable, and all that can be
offered to patients are supportive measures.
Given the clinical importance of cone loss in retinal degener-
ative disease, in our effort to develop broad-based therapies for RP
that go beyond single gene replacement, we have been studying
the mechanisms of cone cell loss. We and our colleagues have
demonstrated that rods secrete factors that promote cone survival,
reviewed in [7]. Furthermore, through expression and homology
cloning approaches, we have identified a novel family of rod-
secreted factors that are trophic for cones. These factors, Rod-
Derived Cone Viability Factor (RdCVF) and RdCVF2, are
encoded, respectively, by the nucleoredoxin-like genes NXNL1
and NXNL2 [8,9]. The cone-directed protective activity of retinal
explant conditioned media is significantly reduced after immuno-
depletion of RdCVF, suggesting that a major part of retinal
derived cone survival activity in vivo is due to RdCVF [8]. The
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loss of expression of RdCVF by rods as well as by bipolar cells at
the onset of cone degeneration [8,10]. The potential of RdCVF
administration for promoting survival of the central vision
attributable to cones in patients suffering from RP is well
illustrated by the finding that injection of RdCVF protein in the
P23H transgenic rat model of dominant RP both slows down
secondary cone loss and, more importantly, preserves cone
function as measured by electroretinography [11].
Both RdCVF and RdCVF2 are encoded by an unspliced
transcript from their respective genes. NXNL1 and 2 also express a
spliced mRNA that encodes the protein products RdCVFL and
RdCVF2L, which unlike RdCVF and 2 contain an entire
thioredioxin-fold [9]. This suggests that the mammalian nucleor-
edoxin-like genes are bi-functional, with one mRNA encoding a
cone survival factor and a second encoding an active thioredoxin
enzyme involved in the defense against oxidative stress, similar to
the situation reported for the RdCVFL homolog in the arthropod
Carcinoscorpius [12,13]. The search for proteins targeted by the
putative redox-controlling activity of RdCVFL has led to the
identification of a functional interaction between RdCVFL and the
microtubule association protein TAU [14]. The hyperphosphoryla-
tion of TAU in the retina of the mouse carrying a deletion of the
Nxnl1 gene likely plays a role in the degeneration of rods observed in
that model and in also in their sensitivity to oxidative stress [15].
A key element in understanding nucleoredoxin-like signaling in
the eye is the restricted expression of the Nxnl1 and 2 genes in the
retina. Nxnl1 expression is fully restricted to the eye, where it is
expressed prominently by photoreceptors but also by bipolar cells
[8,10]. Although Nxnl2 is expressed in selected regions of the brain
as well as in the eye [9], within the retina RdCVF2 and RdCVF2L
are expressed exclusively by photoreceptor cells. In the rd1 mouse
model of RP, the death of rods (which account for 97% of all
photoreceptors) results in the loss of retinal expression of all the
products of the nucleoredoxin-like genes, including expression of
Nxnl1 from bipolar cells [10]. This highly regulated expression
pattern of the Nxnl1 and 2 genes raised the interesting question as
to what are the mechanisms that control its cellular specificity
within the retina. Understanding the regulation of the RdCVFs is
not only important for what it can teach us about fundamental
questions of cell type-specific gene transcription and processing,
but also because manipulating expression of members of the
RdCVF family could have therapeutic potential. Work from a
number of groups, using a variety of experimental approaches, has
identified some of the transcription factors that mediate photore-
ceptor gene expression. Among the factors identified are CRX,
NRL, NR2E3, RX/RAX, PAX6, and QRX [16–24]. Interest-
ingly, many of these factors are homeodomain proteins, and it
seems that combinatorial use of a relatively small number of
proteins can account for a significant degree of photoreceptor
specificity. Also of interest, mutation of or modulation of the
expression of many of these proteins can cause abnormalities of
photoreceptor development and/or retinal degeneration. For
example, the homeoprotein CRX (cone rod homeobox), which
itself is expressed predominantly in photoreceptors, binds to the
consensus sequence C/TTAATCC/A and has functionally
important binding sites present in the upstream region of many
photoreceptor-specific genes, including rhodopsin, arrestin, IRBP,
and b-phosphodiesterase-6 [18,19,24]. Knock-out of CRX in mice
does not significantly alter photoreceptor lineage decisions, but it
does markedly affect photoreceptor differentiation both morpho-
logically and at the gene expression level [25,26]. In humans,
CRX mutations induce a variety of phenotypes of retinal
degeneration [27].
In a first step towards understanding the regulation of RdCVF
expression, we recently used a combined promoter and transcrip-
tomic analysis to identify some of the transcription factors that
modulate Nxnl1 expression, and among the factors identified were
the homeoproteins CHX10/VSX2, VSX1, and PAX4, and the
zinc finger protein SP3 [10]. Here, we have extended that analysis
and focused on the cis-acting 59-upstream regulatory sequences in
both the murine and human Nxnl1 and 2 genes. Since a
bioinformatic evolutionary comparison analysis (phylogenic foot-
printing) did not reveal significant sequence conservation between
the 59-regions, we utilized an experimental approach consisting of
transient transfection of luciferase reporter constructs in four
distinct cell lines and ex vivo electroporation of mouse retinal
explants with GFP reporter plasmids. The use of the retinal
explants allowed analysis of cell type-specific elements. We
mapped active proximal promoter regions in both species to small
regions of the Nxnl1 and Nxnl2 genes. The expression pattern of
the electroporated GFP-reporters showed that while the identified
Nxnl1 promoter sequence specifies expression to photoreceptor
cells, the identified Nxnl2 active promoter fragments are not
sufficient to restrict reporter expression to photoreceptors.
However, we did find that combining a minimal and inactive
134 base pair (bp) piece of the Nxnl1 promoter with an active
79 bp piece of the Nxnl2 upstream region could restore
photoreceptor specificity. This suggested that the 134 bp Nxnl1
sequence contains sufficient information for photoreceptor spec-
ificity. Furthermore, by mutation analysis we showed that a CRX
binding element located within the 134 bp Nxnl1 fragment is
necessary for promoter activity, thereby implicating CRX in the
cell type-specific regulation of RdCVF expression.
Results
Mapping the transcriptional start sites of the murine and
human NXNL1 and NXNL2 genes
In order to delineate the 59 upstream regions of the mouse and
human NXNL1 and NXNL2 genes, we determined the position of
their putative transcriptional start sites (TSSs) by rapid amplifica-
tion of cDNA ends (RACE), using RNA purified from mouse and
human retinas. As negative controls, we performed the reactions
using RNA isolated from the retina of the Nxnl1 and Nxnl2 knock-
out mice since the strategy used to generate these animal models
results in the elimination of their respective mRNAs [15] and
Jaillard et al., (submitted). Additionally, as control for human
retinal tissue, we used HeLa cells (ATCC CCL-2) since northern
blot analysis showed that NXNL1 transcripts are not expressed by
these cells in Audo et al., (manuscript in preparation). As expected,
RACE-PCR products for both Nxnl1 and 2 were present with
wild-type (wt) retina, while with Nxnl1-/- RNA only a product for
Nxnl2 was generated, and with Nxnl2-/- RNA only a product for
Nxnl1 was generated (Figure 1A). In addition, we confirmed that
both NXNL1 and NXNL2 are expressed in the human retina and
that HeLa cells express NXNL2 but not NXNL1. The products of
the RACE reactions were cloned, analyzed by gel electrophoresis
and representative clones were sequenced (Figure 1B). Three and
four retinal putative TSSs were identified for the mouse Nxnl1 and
Nxnl2 genes, respectively, three for human retinal NXNL1, and
only one for human retinal NXNL2 (Figure 1C). For nomenclature
purposes, we have chosen to label the nucleotides in each gene
based on the position of its major putative TSS (+1) (since Nxnl1
had two major TSSs of similar strength, one at 268 bp and one
252 bp, we arbitrarily chose to use the one at 252 bp for
labeling). Interestingly, while as noted above NXNL2 is expressed
by HeLa cells, its major putative TSS in HeLa cells is at 272 bp,
CRX Regulates RdCVF
PLoS ONE | www.plosone.org 2 October 2010 | Volume 5 | Issue 10 | e13075Figure 1. Identification of the putative transcriptional start sites (TSSs) of the NXNL1 and NXNL2 genes. (A) Gel electrophoresis analysis
of the RACE products. (B) Gel electrophoresis of the cloned RACE products. Arrowheads indicate the products that were sequenced. The numbers
indicate the position of the putative TSSs relative to the ATG translation initiation codon. (C) Positions of the putative TSSs mapped onto the genomic
sequences of the NXNL genes using the ATG as reference (+1). In all subsequent figures and in the text the position of the major putative TSS is
defined as +1.
doi:10.1371/journal.pone.0013075.g001
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mechanism controlling its expression in photoreceptor versus
HeLa cells.
Murine and human NXNL1 and NXNL2 promoter activity
in retinal and non-retinal cell lines
In most instances, the major DNA elements regulating
promoter activity are located in the 59-upstream region of a given
gene [28–30]. In order to map the promoter regions of the murine
and human NXNL1 and NXNL2 genes, we used PCR to construct
a collection of reporter plasmids containing various sequences 59
to the respective gene’s ATG site into the promoterless luciferase
reporter vector pGL4.17. The human samples were generated
from DNA that was derived from a single donor’s white blood
cells. DNA sequencing of the resultant constructs, as well as
sequencing of additional independent PCR products, and
comparison with the UCSC database revealed both previously
identified and novel sequence variants within the upstream regions
of both the NXNL1 and NXNL2 genes (since the term
‘‘polymorphism’’ is generally used to refer to sequence variants
that occur at a frequency of at least 1% in a population, and we do
not have any frequency data on the variants we identified, in the
text below we will refer to these as ‘‘sequence variants’’). The
identity and location of the detected sequence variants and their
occurrence within the various reporter constructs studied are
noted in the appropriate figure legends. For initial analysis,
reporter plasmids were transfected into the Y79 retinoblastoma
cell line, which based on the NCBI EST database expresses
RdCVF, and into the non-retinal cell line HEK 293, which was
derived from adenoviral DNA transformed human embryonic
kidney cells [31]. The activity of the various promoter constructs
was measured using a dual luciferase assay to normalize expression
relative to that of a HSV-thymidine kinase promoter (pRL-TK-
renilla), and the data are presented as fold induction compared to
the empty pGL4.17 plasmid.
With the NXNL1 transfection series and Y79 retinoblastoma
cells, we found similar levels of reporter activity with the 22072 to
+57 bp, 21034 to +57 bp, and 2501 to +57 bp constructs
(Figure 2A). In HEK 293 cells we found similar levels of reporter
activity with the 21034 to +57 bp and 2501 to +57 bp constructs,
but observed significantly less activity with the 22072 to +57 bp
construct, suggesting that a negative DNA element(s) active in 293
cells, but not in the retina, might be present in the 22072 to
21034 bp region. Using an analogous approach with a set of
shorter deletion constructs, we localized much of the promoter
activity to the immediate upstream sequence in Y79 cells, and
probably also HEK293 cells, to the region between 2205 and
277 bp (Figure 2A). Here again, there is a suggestion of a negative
regulatory element specific to HEK 293 cells, this time localized to
the 2400 to 2205 bp region.
In contrast to these findings of significant promoter activity with
the human NXNL1 upstream region, with murine Nxnl1 we
identified only minimal promoter activity with the constructs
tested (Figure 2B). Similar results were obtained with two other cell
lines, the mouse cone-like line 661W [32] cells and COS-1 cells,
derived from African green monkey kidney cells (Figure S1). As
noted above, there is surprisingly little sequence conservation
between the murine and human NXNL1 upstream regions. Thus
one possible explanation for the mouse constructs lack of
significant promoter activity with the monkey and human cells is
that they may lack the transcription factors necessary to recognize
the murine regulatory elements, and based on the results with
mouse retinal explants (see below), this does seem likely to be at
least part of the explanation (Figure 2B). However, species
difference does not explain the difference observed with the
murine 661W cells.
In the case of the NXNL2 gene, contrary to that observed with
NXNL1, relative promoter activity was higher in the non-
photoreceptor cell line HEK 293 than in Y79 cells (Figure 2C).
The major component of the observed positive regulatory activity,
in both HEK293 and Y79, cellswas localized to the region between
2393 and 2315 bp (Figure 2C). As with the human gene, the
murine Nxnl2 promoter constructs were also considerably more
active in HEK 293 than in Y79 cells (Figure 2D). The step-wise
reduction in activity observed with the shorter deletion constructs in
the HEK 293 cells suggests the presence of multiple regulatory
elements,eachof moderate activity (Figure 2D). Comparable results
were obtained with 661W and COS-1 cells (Figure S1).
Murine and human NXNL1 and NXNL2 promoter activity
in electroporated mouse retinal explants
Based on the lack of clear retinal specificity in the above
described cell line studies, which in fact was not surprising given
the clear importance of cellular environment on transcriptional
activity, we switched to electroporation of perinatal mouse retinal
explants, an ex vivo approach that we thought would be more
amenable to analysis of retinal cell-specific promoter elements.
Prior studies by Matsuda and Cepko had shown that mouse retina
can be transfected reasonably efficiently by electroporation and
that in these experiments retinal promoters tend to retain their cell
type specificity [33,34]. Using an adaptation of their methods, we
performed electroporation with various green fluorescent protein
(GFP) reporter constructs analogous to the previously described
Nxnl1 and Nxnl2 luciferase constructs, and then quantified the
activity of the promoter fragments by measuring the cellular
fluorescence of the electroporated retinas. Mouse retinal explants
were electroporated at post-natal day 0 (P0) and maintained in
culture 5 days. Fluorescent signals were captured with a Charge
Coupled Device (CCD) camera. Using this approach, although
there was certainly significant variation from electroporation to
electroporation, even with the same construct, we were able to
observe fluorescent signals whose intensity was highly dependent
upon the upstream sequence contained in the reporter construct.
For example, with human NXNL1, we observed fairly similar
expression levels with the 22072 to +57 bp, 2501 to +57 bp, and
2205 to +57 bp constructs, but when the upstream region was
deleted to 277 to +57 bp there was essentially complete loss of
activity (Figure 3A). Although consistent in a general sense with
the pattern of the Y79 and HEK 293 results, quantitatively the
mouse retina result was significantly different in that with the cell
lines the decrease in activity with deletion of the 2205 to 277 bp
region resulted in only a 40% decrease in activity (Figure 2A).
Other differences between the cell line and retinal explant results
were even more striking. Unlike with the cell lines, in the mouse
explants the murine Nxnl1 promoter constructs are more active
than the human NXNL1 (compare Figure 2A-B with Figure 3A-B).
With the cell lines, the Nxnl1 construct with the maximal activity
was the 277 to +51 bp fragment (Figure 2B), whereas this
construct had no detectable activity in the explant system
(Figure 3B). The consistently low activity of the 21749/+51 bp
construct in the explant system compared to the 2924 to +51 bp
construct most probably indicates the presence of a negative
regulatory element located between 21749 and 2924 bp.
With the NXNL2 promoter constructs, the retinal explant results
were fairly consistent with those obtained with the cell lines
(compare Figure 2C and Figure 3C). As with the cell lines, the
sequence from 2393 to 2315 bp was required for significant
promoter activity. This finding delineates a region of 79 bp (2393
CRX Regulates RdCVF
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intensity of GFP fluorescence was lower with the longer NXNL2
constructs (22033/+27 and 2519/+27), suggesting the presence
of a negative element in the more far upstream region.
Surprisingly, the murine Nxnl2 constructs tested with the mouse
explants showed minimal and inconsistent activity, although it was
clear that the 2195 to +70 region did have some activity
(Figure 3D).
We have previously reported that the temporal pattern of
expression of RdCVF and RdCVF2 mRNA in the retina of the
mouse shows increasing expression during development that then
plateaus when the retina reaches its mature state, a pattern that is
fairly similar to that of rhodopsin except that the actual level of
expression is considerably lower [8,9]. As part of our character-
ization of the various NXNL1 and NXNL2 promoter fragments, we
performed a time course study with the retina explants, and also
tested the bovine rhodopsin 2.2 kb promoter (22174/+70) as a
comparative control [35]. A plasmid containing the 22174/+70
rhodopsin sequence upstream of red fluorescent protein (RFP) was
co-electroporated with part of the deletion series of NXNL1 and
Figure 2. Relative activity of murine, human NXNL1 and NXNL2 upstream region promoter fragments in HEK 293 and Y79 cells. (A)
Human NXNL1 constructs. (B) Mouse Nxnl1 constructs. Sequence positions are numbered with the major putative TSS defined as +1. Luciferase values
were normalized to control (pRL-TK) and the results are plotted as fold induction compared to pGL4.17 control plasmid. Values represent the average
of at least three independent experiments, each done in triplicate. Error is shown as SEM. **p,0.01, ***p,0.001. The human constructs used in this
and subsequent figures contain a C/T sequence variation at position -30 (T is the consensus sequence at this position) and an A/G sequence variation
at position -8 (A is the consensus sequence at this position). The 277/+57 construct has a T at position -30 and a G at position -8; the 2205/+57
construct has a T at position -30 and G at position -8; the 2400/+57 construct has a T at position -30 and A at position -8; the 2501/+57 construct has
a C at position -30 and A at position -8; the 21034/+57 construct has a T at position -30 and G at position -8; and the 22072/+57 construct has a C at
position -30 and A at position -30. (C) Human NXNL2 constructs. (D) Mouse Nxnl2 constructs. Luciferase activity was normalized to control (pRL-TK)
and the results are plotted as fold induction compared to pGL4.17 control plasmid. Values represent the average of at least three independent
experiments done in triplicate. Error is shown as SEM. **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0013075.g002
CRX Regulates RdCVF
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daily over a period of 8 days and the intensity of the signal was
quantified (Figure 4). As expected, the intensity of RFP
fluorescence increased over this time period, corresponding to
the postnatal differentiation of the retina. The pattern of
expression of the NXNL1 and NXNL2 promoters differed
temporally from each other in that the NXNL1 constructs showed
a continuous increase in activity with time whereas the NXNL2
constructs tended to show an early peak, usually at 1 day, and then
show a decrease with time. The same regions that showed positive
promoter activity in the single time-point studies, 2205 to 278 bp
and 2351 to 278 bp for NXNL1 and Nxnl1, respectively, were
found to be important for the observed temporal increase in
promoter activity.
Murine and human NXNL1 promoter constructs drive
expression of GFP specifically in photoreceptors
We next investigated the cell type specificity of the various
promoter regions by determining the spatial distribution of GFP
and RFP positive cells in slices of retinal explants 5 days after co-
electroporation with the rhodopsin and NXNL1 and NXNL2
promoter constructs. With the human NXNL1 construct, 2205/
+57 GFP positive cells were observed exclusively in the outer
nuclear layer, the part of the retina that corresponds to
Figure 3. Mapping the active regions of the murine and human NXNL1 and NXNL2 promoter constructs using electroporation of
mouse retinal explants. Retinal explants were electroporated at P0 with the GFP expression vector driven by different fragments of the Nxnl
promoters and cultured for 5 days in vitro (DIV5). (A) NXNL1 (B) Nxnl1 (C) NXNL2 (D) Nxnl2. The intensity of fluorescence of a GFP reporter under the
control of the chicken b-actin promoter (pCIG) is provided for comparison.
doi:10.1371/journal.pone.0013075.g003
CRX Regulates RdCVF
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localization of GFP and RFP in a substantial number of cells,
indicating that the NXNL1 promoter construct is active in rods.
The construct might also be active in cones as seen by the two
GFP-positive/RFP-negative cells at the upper right corner of the
panel, but this issue remains to be more definitively resolved. The
results were quite similar with the mouse Nxnl1 construct 2351/
+51 (Figure 5B), but by examining more extensively the labeled
slices, we could identify some GFP positive cells in the inner part of
the retina as represented in the merged portion of the panel. These
non-photoreceptors cells where the Nxnl1 promoter is active are
likely to be bipolar cells, because endogenous RdCVF mRNA is
also expressed by bipolar cells [10]. These observations demon-
strate that the 2205 to +57 bp human NXNL1 sequence and the
2351 to +51 bp murine Nxnl1 sequence are each sufficient, at least
in retinal explants, to drive the expression of RdCVF specifically in
photoreceptors.
The results were strikingly different when retinal explants were
electroporated with GFP driven by the mouse and human NXNL2
promoter 59-upstream regions. With the human -393/+27 NXNL2
promoter construct, GFP-positive cells were observed mostly in the
inner part of the retina (Figure 5C) - the difference from the
rhodopsin promoter can be easily appreciated by the absence of
co-localization in the merged image. A similar situation was
observed with the mouse Nxnl2 2382/+70 construct (Figure 5D).
The GFP pattern of expression resembles that of Muller glial cells.
The absence of expression of these Nxnl2 reporters in photore-
ceptor cells cannot be attributed to the lack of transfection of the
plasmids into photoreceptors since we could visualize RFP-positive
rods in the same retinal explants. Similar results were obtained
whatever the length of the upstream regions for both the human
and mouse NXNL2 genes (data not shown), demonstrating that
important photoreceptor-specific elements regulating the expres-
sion of Nnxl2 in photoreceptor cells are likely localized outside the
4.5 kb 59-upstream region that we tested.
The NXNL2 -393 to -315 bp region contains a positive
transcriptional regulator and the NXNL1 277 to +57 bp
region contains a photoreceptor-restricting element
Our mapping analysis of the human NXNL2 promoter indicated
the presence of a positive regulatory element located between
2393 and 2315 bp that is active in the retina but that is not
sufficient to provide photoreceptor specificity (Figure 3C and data
not shown). To determine whether 79 bp sequence requires other
elements of the NXNL2 promoter not included in the constructs for
its activity, we separated it from the rest of the RdCVF2 promoter,
by cloning it into pGL4.17 immediately upstream of the NXNL1
promoter sequence from 277 to +57 bp (79+134, Figure 6A). We
chose the 277/+57 NXNL1 fragment as the scaffold for these
experiments because this minimal promoter sequence contains
needed core RNA polymerase II binding elements, since it is active
in Y79 and HEK 293 cells (Figure 2A), but it is by itself insufficient
for transcriptional activity in the more stringent and biologically
relevant environment of retinal explants (Figures 3A and 4). When
transfected into HEK 293 cells, the 79+134 fusion construct
stimulated luciferase activity approximately 5-fold over the basic
277/+57 construct (Figure 6B). When both constructs were tested
using the retinal explant assay, the 277/+57 human NXNL1
construct was found to be inactive as observed earlier (Figures. 3A
and 4). However, the 79+134 fusion construct was active, and
perhaps surprisingly, its activity was found to be photoreceptor-
specific (Figure 6C-D). The merged image confirmed that the
GFP-positive cells, which were only observed within the ONL,
were also rhodopsin (RFP) expressing cells.
A CRX element controls the expression of RdCVF and is
responsible for its photoreceptor-specific expression
We took a bioinformatics approach, using Genomatix promoter
analysis software, to try to identify elements within the NXNL1
277/+57 region that could account for its biological activity. The
analysis identified four binding elements corresponding to
transcription factors reported to be expressed specifically or
preferentially in the eye (CRX, MAF, POU1F1, and POU3F4). A
similar analysis was performed on the mouse Nxnl1 2352/+51
promoter sequence and two transcription factors specific to the eye
were found to be common between the two analyses: a MAF-
response element half site and a putative CRX binding element.
Although MAF-response element half sites can show activity,
usually less than that observed with full sites [36], we chose to
concentrate our efforts on the putative CRX sites, located at
position 256 to 250 bp in the human gene and at 254 to
248 bp in the murine gene. The contribution of the identified
CRX binding elements to NXNL1 promoter activity was assessed
by mutating the TAA in the TAAT core recognition site to CCG
in the human and mouse 2205/+57 and 2353/+51 promoter
constructs, respectively. We choose the CCG mutation because
this change has been previously reported to abolish CRX binding
to DNA [37]. The wild-type and mutated human constructs were
tested in Y79 cells, which express CRX as indicated by RT-PCR
analysis (result not shown). As expected, the wild-type -205/+57
NXNL1 construct was active, but when the CRX site was mutated
promoter activity dropped to that of the empty luciferase control
vector (Figure 7A). We then tested the effect of CRX mutation of
the human and murine constructs in a time-course analysis in the
retinal explant system (Figure 7B). Mutation of the CRX site led to
complete elimination of promoter activity for both the human and
murine constructs. These results demonstrate that the proximal
CRX binding element present in the human and mouse Nxnl1
upstream regions is necessary for their promoter activity.
We also tested the effect of the mutation of the proximal CRX
binding element in the 79+134 NXNL2/NXNL1 fusion construct.
In the Y79 assay, the NXNL1 CRX mutation within the fusion
construct led to loss of promoter activity, just as observed with the
NXNL1 -205/+57 construct (Figure 7A). When tested in the ex vivo
retinal explant assay, the CRX mutation in the context of the
fusion construct did not lead to loss of promoter activity
(Figure 8A-B). However, the CRX mutation did lead to a major
change, a loss of photoreceptor specificity, as shown by the
presence of multiple GFP positive cells within the inner part of the
electroporated retina (Figure 8C).
Discussion
Our objective in this study was to begin to elucidate the cis-
elements and trans-factors that control the retinal expression of the
trophic factors RdCVF and RdCVF2, which are encoded by
Figure 4. Temporal activity of the murine and human NXNL1 and NXNL2 promoter constructs in electroporated retinal explants. GFP
fluorescence was monitored daily from DIV1 to DIV9. The RFP expression driven by bovine rhodopsin promoter was used as positive control.
Quantification of the fluorescence of the retinal explants. GFP expression NXNL1, Nxnl1, NXNL2 and Nxnl2, and RFP for rhodopsin at DIV2, 3, 4, 6 and 8.
Values represent the average of at least three independent experiments done in triplicate. Error bars represent SEM.
doi:10.1371/journal.pone.0013075.g004
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transfection analysis of a deletion series of murine and human
Nxnl1 and Nxnl2 59-uptream region reporter constructs using both
retinal (Y79 and 661W) cell and non-retinal (HEK 293 and COS-
1) cell lines. While promoter activity could be detected for a
number of the constructs, the absence of evidence of cell-type
specificity, i.e. absence of clear and consistent differences in
promoter activity for the various constructs between the retinal
and non-retinal cell lines, led us to utilize a more physiological
assay for assessing retinal promoter activity. Although mouse
transgenic studies are considered by many to be the gold standard
for examining the cellular and temporal specificity of promoters,
such studies are limited by position effects and the by the costs and
time involved. As an intermediate approach that combines the
practical advantages of cell line based approaches with the cellular
specificity of transgenic studies, we adapted the electroporation of
mouse retinal explants to provide rapid and reproducible
quantitation of cell-specific promoter activity. Significantly, we
Figure 5. Cell-restricted expression of the murine and human NXNL1 and NXNL2 promoter constructs. Electroporated retinal explants
were sectioned at DIV6, fixed and stained with antibodies against GFP (green, NXNL constructs) and RFP (red, rhodopsin construct marking rod
photoreceptors). (A) NXNL1 (B) Nxnl1 (C) NXNL2 (D) Nxnl2. ONL: outer nuclear layer; INL: inner nuclear layer; and GCL: ganglion cell layer.
doi:10.1371/journal.pone.0013075.g005
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constructs, differed depending upon whether we performed the
assays with the cell lines versus the retinal explants, with the
explants giving stronger evidence of cell-type specificity. For
example, with the Y79 cell assay the NXNL1 -77 to +57 bp
construct retained considerable activity compared to the 2205 to
+57 bp construct, while in the more stringent explant system the
59 deletion from 2205 to 277 bp led to loss of all detectable
promoter activity, indicating that the deleted region contained a
sequence with regulatory function that was essential in retinal cells
but not in the cell lines tested. This suggests that the activity of the
Nxnl1 promoter, like that of other genes that show highly cell-type
restricted expression patterns, is regulated by transcription factors
that are sensitive to the cellular context of the cell. Of even greater
significance, as demonstrated with the NXNL1 and NXNL1/2
fusion gene studies, the explant system allows analysis of cell type
Figure 6. NXNL1 proximal promoter region, which itself lacks promoter activity, confers photoreceptor-specificity to a NXNL2
promoter region with positive regulatory activity. (A) Schematic diagram of the 79+134 construct, which consists of the NXNL1 sequence
extending from 277 to +57 bp fused to the NXNL2 sequence extending from 2393 to 2315 bp. In terms of the sequence variants mentioned above,
it has a C at position -30 and a G at position -8. (B) Transient transfection analysis performed in HEK 293 cells and normalized to control (pRL-TK). The
results are expressed as fold induction compared to the NXNL1 277/+57 construct. Values represent the average of at least three independent
experiments done in triplicate. Error is shown as SEM. (C) Mouse retinal explants electroporated at P0 and maintained in culture for 8 days. (D) Retinal
explants were sectioned at DIV8, fixed and stained with anti-GFP (green) and anti-RFP (red) antibodies. ONL: outer nuclear layer; INL: inner nuclear
layer; and GCL: ganglion cell layer. ***p,0.001.
doi:10.1371/journal.pone.0013075.g006
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PLoS ONE | www.plosone.org 10 October 2010 | Volume 5 | Issue 10 | e13075Figure 7. The proximal CRX binding element controls activity of the mouse and human NXNL1 promoters. (A) Transient transfection
analysis performed in Y79 cells with NXNL1 2205/+57 and the 79+134 NXNL1/NXNL2 fusion construct. The 2205/+57 wt and CRX mutant constructs
both have a T at position -30 and an A at position -8. Luciferase activity was normalized to control (pRL-TK) and the results displayed as fold induction
compared to the pGL4.17 control plasmid. Values represent the average of at least three independent experiments done in triplicate. Error is shown
as SEM. ***p,0.001. (B) P0 mouse retinas were electroporated with the RFP rhodopsin expression construct and the indicated GFP construct.
Quantified fluorescence intensity of the electroporated retinal explants. Comparison of NXNL1 2205/+57 wild-type (wt) and CRX mutant constructs
(mut). The 2205/+57 wt and CRX mutant constructs both have a T at position -30 and an A at position -8. Comparison of Nxnl1 2351/+51 wild-type
(wt) and CRX mutant constructs (mut).
doi:10.1371/journal.pone.0013075.g007
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ate and provide a powerful system to reveal potent cis-acting
elements with broad cellular spectrum, and also can be useful for
gain of function studies in which non-expressed cell type-specific
trans-acting factors are added to the cells, but are of limited use for
revealing the promoter elements responsible for conferring highly
cell-restricted patterns of expression.
The deletion series of the NXNL1 promoter constructs revealed
a critical region proximal to the transcriptional start site of both
the human (2205 to 277 bp) and mouse (2351 to 277 bp) genes
(Figure 3A and B). Within these regions, cis elements are able to
confer promoter activity to the reporter constructs, and within the
context of more downstream sequences to restrict expression to the
naturally RdCVF expressing cells, photoreceptor cells and, to a
lesser extent, bipolar cells (Figure 5A and B). The promoter
activity scored for these constructs (NXNL1 2205/+87 and Nxnl1
2351/+51) seems to depend on the state of differentiation of the
retinal cells, and mostly of the differentiation state of photorecep-
tors since the activity gradually increases in concert with the
activity of the rhodopsin promoter construct with time (Figure 4).
Figure 8. The proximal CRX binding element within the NXNL1 is important for photoreceptor cell type specificity. P0 mouse retinas
were electroporated with the rhodopsin RFP expression construct and the indicated GFP construct. (A) Comparison of 79+134 wild-type (wt) and
79+134 CRX mutant constructs (mut). The 79+134 wt and CRX mutant constructs both have a C at position -30 and a G at position -8. (B) Quantified
fluorescence intensity of the electroporated retinal explants. (C) Sectioned retinal explants showing the regional localization of reporter expression in
the layers of the retina. ONL: outer nuclear layer and INL: inner nuclear layer. ***p,0.001.
doi:10.1371/journal.pone.0013075.g008
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constructs revealed the existence of a putative CRX binding
element (256 to 250 bp in NXNL1 and 254 to 248 bp in Nxnl1).
Because of the essential role of the homeodomain protein CRX in
the maturation of photoreceptors and its implication in inherited
photoreceptor degeneration [18,38,39,25], the role of this binding
element was further analyzed by mutagenesis. The integrity of the
CRX binding element was found to be essential for the activity of
the Nxnl1 promoter in vitro and ex vivo (Figures 7A and B). While we
cannot rule out the possibility that another promiscuous
homeodomain protein regulates the expression of RdCVF through
this ‘‘CRX’’ element, CRX it is the most likely candidate to be
mediating the observed biological activity.
The deletion analysis of the human NXNL2 gene identified a
79 bp promoter element that showed promoter activity in both the
cell line and retinal explant assay systems (Figures 2C and 3C).
The activity of this element is not restricted to photoreceptor cells
(Figure 5C). Interestingly, this 79 bp sequence is active when fused
to an inactive 134 bp NXNL1 minimal proximal promoter
sequence (Figure 6B and C), resulting in a reporter expression
pattern that shows restriction to photoreceptors (Figure 6D). These
findings demonstrate that the NXNL2 79 bp sequence from 2393
to 2315 bp contains positive regulatory activity that can act
independently of its own basal promoter and also strongly suggest
that the NXNL1 277 to +57 bp proximal promoter region
contains sufficient cell type-specific information, when supple-
mented with a less specific transcriptional activator, to restrict
expression to photoreceptor cells. The identity of the biologically
active regulatory elements within the 79 bp NXNL2 sequence, and
the transcription factor(s) that bind to them, are presently
unknown. For the cell type restricting activity of the 134 bp
NXNL1 region, the putative CRX binding site discussed above
appears to be important. Mutation of the CRX element abolished
promoter activity of the NXNL2/NXNL1 fusion construct in Y79
cells (Figure 7A). Although mutation of the CRX site did not
significantly reduce promoter activity in the explant system, it did
lead to loss of photoreceptor specificity (Figure 8). These results,
taken together, suggest that the CRX site within the NXNL1
proximal promoter region plays a dual function depending on its
context. Within the native NXNL1 promoter it appears to act as a
positive transcriptional regulator whose activity is essential for
expression. Without its activity there is no detectable expression so
in this context its possible role in influencing cell type specificity
cannot be assessed. In the context of the NXNL2/NXNL1 fusion
construct, presumably because an element, or elements, within the
79 bp NXNL2 sequence is able to replace its transcriptional
activating role, its function in restricting expression to photore-
ceptors is unmasked. Future studies will hopefully provide
mechanistic insight into how CRX carries out these dual roles,
and also provide information on the other regulatory sites and
factors responsible for the photoreceptor expression of RdCVF
and RdCVF2.
Materials and Methods
Animals
No animal experimentation was performed. The animals used
in this study were obtained from Charles River France
(L’Arbresle). Retinal tissues were obtained from newborn
C57BL/6 mice. Animals were sacrificed the day of birth and eyes
were dissected to recover neural retinal tissues (Authorization 75–
1208 delivered on July 21 2008 by the Minister of Agriculture).
The methods used to secure animals and tissues complied with the
ARVO Statement fro the Use of Animals in Ophthalmic and
Vision Research. No animal experimentation was performed. The
animals used in this study were obtained from Charles River
France (L’Arbresle).
Rapid Amplification of cDNA Ends (59 RACE)
The rapid amplification of cDNA ends (59 RACE) was carried
out using total RNA purified from mouse retina, human retina
and cultured HeLa cells by CsCl2 ultracentrifugation. A First-
Choice
TM RLM-RACE Kit (Ambion) was used to identify
transcription start sites according to manufacturer’s instructions.
Briefly, total RNA was treated with calf intestinal phosphatase to
remove the 59-phosphate. The RNA was then treated with
tobacco acid pyrophosphatase to remove the cap structure of the
mRNA. A synthetic RNA adapter was then ligated to the RNA
population to allow ligation to only RNA having been capped.
After reverse transcription reaction, cDNA was obtained by
nested-PCR using two reverse primers for each gene (human
NXNL1:5 9 CCGCCCGCAGTACATAGAACTCA 39 and 59
TCTGTGAGCCGCACGAAGAAGTC 39; mouse Nxnl1:5 9 TC-
AGCACGTCCCCACCAG GCTTAA 39 and 59 TCAGCACG-
TCCCCACCAGGCTTAA 39; human NXNL2:5 9 GCGCAT-
GAAGTCCAGCATCTCC 39 and 59 TCGGCTGACACGAA-
GACCACTTC 39; mouse Nxnl2:5 9 CGTTCTGCTTGATGAC-
CACCAGC 39 and 59 GGGGATGGCGGTGAT TTCGTA 39)
and the two forward primers provided with the kit. PCR products
were analyzed on 2% agarose gels and the reaction products were
cloned into pGEM T Easy (Promega). A subset of recombinant
clones were analyzed on agarose gel and the plasmid displaying
different insert sizes were sequenced from both directions. Theses
sequences were aligned to the genomic sequences.
Cell culture
Human Y79 cells from an immortalized cell line derived from a
human retinoblastoma (ATCC HTB-18) were cultured in RPMI
1640 medium supplemented with 10% fetal bovine serum. Cells
were maintained in suspension or for transfection purposes were
grown as a monolayer. For cell attachment, plates were treated
with poly (D-lysine) (0.2 mg/ml, Sigma) and laminin (0.1 mg/ml,
Sigma) for 3 hours at 37uC. Human HEK 293 cells (ATCC CRL-
1573) and COS-1 cells (ATCC CRL-1650) were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum (FBS, Invitrogen). 661W cells (murine
cone photoreceptor derived cells) were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum (FBS, Invitrogen) and 2mM L-glutamine (Invitro-
gen). HeLa cells (ATCC CCL-2) were cultured in RPMI 1640
medium supplemented with 10% fetal bovine serum. Cell media
were changed every 2–3 days, and cells were split weekly.
Promoter reporter plasmids construction
The sequence upstream ATG of both murine and human Nxnl1
and Nxnl2 were cloned in the promotorless pGL4.17 (expressing a
firefly luciferase, Promega) and peGFP (Clontech) plasmid using
the gateway technology (Invitrogen). The vectors were converted
into a gateway destination vector by introducing a cassette
containing the attR sites flanking the ccdB gene into the multiple
cloning site. To identify DNA sequences that regulate murine and
human Nxnl1 and Nxnl2 transcription, a series of deletions from the
59 end of each gene was created. Primers were designed to amplify
different lengths of the 59end regions of each gene, from
approximately 100 base pairs (bp) to 4.5 kb and the attB sites
were incorporated into the forward (attB site 59 GGG GAC AAG
TTT GTA CAA AAA AGC AGG CTT A 39) and the reverse
(attB site 59 GGG GAC CAC TTT GTA CAA GAA AGC TGG
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each construct except the CRX mutant and wild-type constructs
(see below). The PCR reactions were performed using murine and
human genomic DNA as the template and were subjected to a hot
start of 5 min at 94uC prior to the addition of the Platinium Taq
DNA Polymerase High Fidelity (Invitrogen) followed by 7 cycles
amplification: denaturing for 25 sec at 94uC, annealing for 30 sec
to 7 min at 66uC (depending on the size of the PCR product), 35
cycles amplification: denaturing for 25 sec at 94uC, annealing for
30 sec to 7 min at 60uC (depending on the size of the PCR
product) and a final extension at 66uC for 10 min. The primers
used for each construct were listed in Table S1. The PCR products
were purified after gel agarose electrophoresis using the gel
extraction kit (Qiagen). The BP reaction was performed using
300 ng of the PCR product, 300 ng of the pDONR vector
(Invitrogen), 4 ml of the BP Clonase Reaction Buffer (Invitrogen)
and 4 ml BP Clonase enzyme mix (Invitrogen) to obtain entry
clones. The reaction was incubated one hour at room tempera-
ture. OneShot TOP10 chemically competent E.coli cells (Invitro-
gen) were transformed by using 5 ml of the BP reaction. Positive
clones were identified by restriction enzyme analysis of purified
plasmid and verified by DNA sequencing. The LR reaction was
performed by using 300 ng of the entry clone, 300 ng of the
destination vector (pGL4.17 or peGFP), 4 ml of LR Clonase
Reaction Buffer (Invitrogen) and 4 ml of the LR Clonase enzyme
(Invitrogen) to obtain the expression vectors. The reaction was
incubated one hour at room temperature. OneShot TOP10
chemically competent E.coli cells (Invitrogen) were transformed by
using 5 ml of the LR reaction. Positive clones were identified by
restriction enzyme analysis.
Construction of mutated CRX binding site
Plasmids containing a mutated CRX binding site (the TAA in
the TAAT core recognition site was modified to CCG) were
generated by DNA synthesis (DNA2.0) and cloned in pDONR.
The LR reaction was performed as previously described to
subclone the sequences into pGL4.17 and peGFP. For the
synthesis, the consensus sequence from GenBank (NCBI) was
used. Because this sequence contained some sequence variants
from the above described PCR generated constructs (due to both
sequence variations in the donor DNA sample and to nucleotide
differences in the PCR primer sequences) and because for the
CRX mutation analysis we wanted the mutant constructs to differ
from the wild-type constructs only in at the CRX binding site, we
used the synthesized constructs as templates to generate wild-type
constructs that were indeed identical except at the CRX site. A
‘mutagenic’ primer was used to convert the CCG sequence back to
the wild type CRX binding site (TAA) by PCR-based mutagenesis.
The resulting fragment was then used as a mega-primer to amplify
the full-length construct in a second round of PCR amplification.
The full-length wild-type constructs were then cloned back into
pDONR on an AvaI –EcoRV fragment, and the resulting
plasmids were sequenced. Reporter constructs were generated by
Gateway recombination as described above.
RNA extraction and RT-PCR
Total RNA was extracted from Y79 cells using the RNeasy
extraction kit (Qiagen). One microgram of total RNA was reverse
transcribed into cDNA by incubation with 1 ml (500 mM final) of
deoxyribonucleoside triphosphate solution (dNTP), 1 ml of oligodT
(10 mM), 4 ml5 6 reaction buffer, 2 ml of 0.1 M dithiotreitol
(DTT), 1 ml of RNasin an 200 U of superscript II (Invitrogen) to a
final volume of 20 ml. Samples were incubated 1 hour at 37uC and
the enzyme was inactivated at 72uC during 10 min. The resulting
cDNA were amplified in PCRs using Platinium Taq High Fidelity
(Invitrogen) in 2 mM MgSO4, 200 mM dNTP and 50 pmol of
primers. Oligonucleotides used were: human CRX forward: 59
GGC TCT GAA GAT CAA TCT GCC TGA 39, reverse: 59
CCA TAG CTC TGG CCT GAT AGG GAG 39: human
G6PDH forward: 59 ATG TTCGTC ATG GGT GTG AAC C 39,
reverse: 59 AGG GAT GAT GTT CTT CTG GAG AGC C 39.
Cycling protocol was: 94uC, 2 min; 35 cycles of 94uC, 30 sec;
60uC, 30 sec; 72uC, 2 min, followed by a final extension step at
72uC for 5 min. PCR products were run on a 1.5% agarose gel
stained with ethidium bromide and visualized under UV
illumination.
Transient transfection and reporter gene assay
Luciferase activity was determined using a luciferase assay
system (Promega) according to the manufacturer’s protocol.
Briefly, Y79 and HEK 293 cells were plated for 24 h at
respectively 5610
5 and 2610
5 cells/well in 24-well plates. Five
hundred (for Y79) or 100 ng (for HEK 293) of promoter constructs
or the empty vector (pGL4.17) was transiently transfected into the
cells with Lipofectamine 2000 (Invitrogen). Cells were co-
transfected with pRL-TK containing Renilla luciferase gene driven
by the thymidine kinase promoter (Promega). One day after
transfection, cell extract was lysed, and the luciferase activity of the
extract was measured with the luminometer LB-96V (Berthold).
Firefly luciferase activities were normalized by Renilla luciferase
activities and relative luciferase activities were expressed as fold
induction as compared to the empty vector (pGL4.17).
Electroporation of retinal explants
Mouse retinas from newborns were electroporated the day of
birth as described in Matsuda & Cepko [33,40]. Briefly, newborn
retinas were dissected in Hank’s Balance Sodium Salts (HBSS)
without calcium and magnesium (Invitrogen) and were cut into 3
pieces and were submerged in a 1 mg/ml DNA solution. They
were subjected to 5 electric pulses at 25 V with 50 ms duration
and 500 ms intervals using a BTX ECM830 square wave
generator (BTX). Explants were then placed on polycarbonate
filter discs (Dutscher) and cultured in DMEM/F12 medium
(Invitrogen) with 10 mM HEPES pH 7.0 containing 5% FBS
(Invitrogen). Cultures were maintained up to 9 days and media
were changed every 2–3 days. The empty vector pCIG-eGFP used
as control expresses the eGFP under the control of the chicken b-
actin promoter [40].
Image acquisition
The fluorescence of retinal explants was monitored after
electroporation. Fluorescent signals were captured with a macro-
scope Z6 APO (Leica) equipped with a CCD CoolSnap camera
(Roper Scientific). MetaMorph software (Universal Imaging
Corporation) was used to quantify the intensity of the emitted
fluorescence
Immunofluorescence
Retinal explants were fixed with 4% paraformaldehyde (PAF) in
PBS for 10 min and incubated 30 min in 30% sucrose at room
temperature. Retinal explants were frozen in PBS-10% sucrose-
7.5% gelatin using a immersion in dry ice and isopentane. The
samples were cut into 10 mm thick sections and mounted on glass
slides. To reduce non-specific labeling, the sections were incubated
for 2 h at room temperature in blocking solution (PBS, 0.1%
Triton X-100 and 2% goat serum). The sections were incubated
with the primary GFP- (Roche) and RFP- (Mbl) antibodies in
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temperature. Sections were washed three times in PBS and were
then incubated with 4’,6-diamidino-2-phenylindole (DAPI) and
secondary antibodies (goat anti-rabbit AlexaFluor 594 and goat
anti-mouse AlexaFluor 488, Invitrogen) diluted at 1:500 in PBS for
1 h at room temperature. After three washes in PBS, immuno-
labeled sections were mounted with Gel Mount (Biomedia) and
were examined with a DM 5000 microscope (Leica) equipped with
a CCD CoolSnap camera (Roper Scientific).
Statistical Analysis
All experiments were performed at least three times, each in
triplicate. Data are expressed as the means 6 S.E.M. Comparison
of meanswas performed using test. p,0.05 isconsideredsignificant.
Supporting Information
Table S1 Oligonucleotide PCR primers used to generate the
various human and mouse NXNL1 and NXNL2 promoter constructs.
Found at: doi:10.1371/journal.pone.0013075.s001 (0.03 MB
DOC)
Figure S1 Relative activity of murine, human NXNL1 and
NXNL2 upstream region promoter fragments in COS-1 and 661W
cells. (A) Human NXNL1 constructs. (B) Mouse Nxnl1 constructs.
The nucleotide positions of each construct are given in reference
to the major putative TSS for each gene. Luciferase activity was
normalized to control (pRL-TK) and the results are plotted as fold
induction compared to pGL4.17 control plasmid. Values represent
the average of at least three independent experiments done in
triplicate. Error is shown as SEM. **p,0.01, ***p,0.001. (C)
Human NXNL2 constructs. (D) Mouse Nxnl2 constructs. The
nucleotide positions of each construct are given in reference to the
major putative TSS for each gene. Luciferase activity was
normalized to control (pRL-TK) and the results are plotted as
fold induction compared to pGL4.17 control plasmid. Values
represent the average of at least three independent experiments
done in triplicate. Error is shown as SEM. **p,0.01, ***p,0.001.
Found at: doi:10.1371/journal.pone.0013075.s002 (5.06 MB TIF)
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